Understand your body better with the new ECG App from Garmin
Garmin (NYSE: GRMN) has unveiled its FDA-cleared ECG App for the Venu 2 Plus smartwatch, enabling users to record a 30-second ECG and monitor for signs of atrial fibrillation (AFib) anytime. This groundbreaking feature is aimed at enhancing user health management by allowing immediate heart rhythm results on the device and detailed reports via the Garmin Connect app. Available in the United States, the app is part of Garmin's ongoing efforts to innovate health-focused wearable technology. Garmin plans to expand the ECG App to other products and regions pending regulatory approvals.
- FDA clearance for the ECG App enhances Venu 2 Plus smartwatch functionality.
- Users can conveniently monitor heart health, leading to better health outcomes.
- Immediate ECG results provide timely information to users.
- Potential for future expansion of ECG features in additional products and regions.
- None.
FDA-cleared and clinically-validated app lets Venu 2 Plus customers record an ECG and check for signs of atrial fibrillation right from their smartwatch
OLATHE, Kan., Jan. 24, 2023 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the ECG App1, an FDA-cleared app for the Venu® 2 Plus smartwatch that allows users to record their heart rhythm and check for signs of atrial fibrillation (AFib) anytime, anywhere. Customers can use the ECG App to record a 30-second ECG and view their heart rhythm results immediately on the watch or, optionally, later in the Garmin Connect™ smartphone app.
"The ECG App is Garmin's first FDA-cleared smartwatch feature and we are thrilled to offer this revolutionary tool to our customers as another way to stay on top of their health," said Dan Bartel, Garmin vice president of global consumer sales. "During the early stages of AFib, it's common for symptoms to be infrequent, making it difficult to detect in a clinical setting. With the new ECG App, Venu 2 Plus customers can conveniently take an ECG recording anytime and optionally create a report of their results to share with their doctor later."
When customers take an ECG, the ECG App uses sensors on the Venu 2 Plus to record the electrical signals that control how their heart beats. The ECG App then analyzes that recording to detect signs of AFib. Additionally, users have the option to sync their ECG App results to Garmin Connect. Through the Garmin Connect app, customers can view their history of ECG App results and create reports that can be shared with a health care provider.
The ECG App is available now on the Venu 2 Plus for customers in the United States and requires the latest version of the Garmin Connect app before use. Garmin intends to continue to expand its portfolio of products supporting the ECG App and launch it in new regions in-line with necessary regulatory approval. For more information on the ECG App and how to set it up, visit Garmin.com/ECG.
Engineered on the inside for life on the outside, Garmin products have revolutionized the wellness industry. Committed to developing wearables and health measurement tools that help people of all activity levels lead healthier lives, Garmin believes every day is an opportunity to innovate and a chance to beat yesterday. For more information, visit Garmin's virtual newsroom, email our press team, connect with @garminwellness on social media, or follow our adventures at garmin.com/blog.
1 The ECG app is available on the Venu 2 Plus smartwatch (firmware version 11.21) with the Garmin Connect smartphone app (version 4.62). The ECG app is not available in all regions; see Garmin.com/ECG for availability. The ECG app is not intended for use by people under 22 years old. With the ECG app, the Venu 2 Plus smartwatch is capable of generating an ECG similar to a single-lead electrocardiogram.
About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin and Venu are registered trademarks and Garmin Connect is a trademark of Garmin Ltd. or its subsidiaries. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.
Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management's current expectations. The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 25, 2021, filed by Garmin with the Securities and Exchange Commission (Commission file number 0001-411180). A copy of such Form 10-K is available at http://www.garmin.com/aboutGarmin/invRelations/finReports.html. No forward-looking statement can be guaranteed. Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Stephanie Schultz
913-397-8200
media.relations@garmin.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/understand-your-body-better-with-the-new-ecg-app-from-garmin-301728903.html
SOURCE Garmin International, Inc.
FAQ
What is the ECG App by Garmin?
When was the ECG App announced?
Where is the ECG App available?
How does the ECG App work?
What are the future plans for the ECG App?
